Madeleine leads Communications and Government Affairs (CGA) for GSK's Vaccines Commercial Portfolio and Pipeline. Her team develops and delivers corporate communications for Vaccines and leads development of disease awareness campaigns and strategic policy and advocacy initiatives.
Madeleine joined GSK 11 years ago and held roles in Global Corporate Communications and as Head of Communications for Australia & New Zealand before joining Vaccines. In these roles she managed media handling for many high-profile milestones for the company, including the GSK-Haleon demerger, and led CGA strategies for corporate, commercial and R&D priorities.
A biochemistry graduate, Madeleine started her career in medical and scientific communications, then led public awareness and behavior change campaigns for the UK government before joining GSK.